In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1835 News Items found
Pictured: Eric Holland, Franziska Michor, and Desert Horse-Grant
New Center Uses Mathematical Models to Understand Cancer

In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.
Timothy A. Chan
Researchers Link Gene that Causes Parkinson's Disease to Cancer

A multidisciplinary team of Memorial Sloan Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson's disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer.
Samuel Singer
Samuel Singer Appointed Service Chief

Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery.
Postdoctoral researchers discuss a poster presentation
Work of Postdoctoral Researchers Spotlighted at Third Annual Symposium

Each year since 2007, Memorial Sloan Kettering's postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium.
Simon Powell
An Interview With Simon Powell

Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program.
Francis M. Sirotnak
FDA Approves Lymphoma Drug Developed at Memorial Sloan Kettering

Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments.
James Allison
Researchers Design More Effective Cancer Vaccine

Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.
Experimental Breast Cancer Drug Shows Promise in Aggressive Form of Disease

Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.
Dinshaw Patel (left) and David Allis
Linking Histones and Cancer

Structural biologists at Memorial Sloan Kettering Cancer Center are collaborating with biochemists and cell biologists at The Rockefeller University to study how cells read genetic instructions imprinted on histones, DNA's packaging proteins.
Charles Sawyers (left) and Howard Scher
Advances in Development of New Targeted Therapy for Prostate Cancer Show Promise

A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.